中医临床研究
中醫臨床研究
중의림상연구
Clinical Journal of Chinese Medicine
2015年
25期
1-3,4
,共4页
温胆汤%痰浊型%冠心病%危险因子%血糖%血脂%血尿酸%血胆红素
溫膽湯%痰濁型%冠心病%危險因子%血糖%血脂%血尿痠%血膽紅素
온담탕%담탁형%관심병%위험인자%혈당%혈지%혈뇨산%혈담홍소
The Wendan decoction%Tanzhuo type%Coronary heart disease%Risk factor%Blood glucose%Blood lipid%Blood uric acid%Serum bilirubin
目的：观察温胆汤加味对痰浊型冠心病患者的相关危险因子的作用。方法：选择同时符合冠心病西医诊断标准及中医痰浊型诊断标准的病例120例，随机分为治疗组和对照组，每组60例。两组均行西医规范治疗，治疗组加用温胆汤加味，4周为1个疗程，持续3个疗程。观察治疗前后患者的血糖、血脂、尿酸、胆红素等指标的变化情况。结果：两组患者治疗后中医证候积分优于治疗前；组间比较治疗组优于对照组，具有显著性差异（P<0.05）；两组患者治疗后心绞痛疗效优于治疗前；组间比较治疗组优于对照组，具有显著性差异（P<0.05）；两组治疗后心电图较治疗前均有所改变，组间比较无显著性差异（P>0.05）；两组患者治疗后血糖、血脂、尿酸水平明显降低，高密度脂蛋白胆固醇、血清胆红素水平明显升高，与治疗前比较有显著性差异（P<0.05）。组间比较显示治疗组优于对照组，具有显著性差异（P<0.05）。结论：温胆汤加味对痰浊型冠心病患者的相关危险因子（血糖、血脂、尿酸、胆红素）有明显改善作用。
目的：觀察溫膽湯加味對痰濁型冠心病患者的相關危險因子的作用。方法：選擇同時符閤冠心病西醫診斷標準及中醫痰濁型診斷標準的病例120例，隨機分為治療組和對照組，每組60例。兩組均行西醫規範治療，治療組加用溫膽湯加味，4週為1箇療程，持續3箇療程。觀察治療前後患者的血糖、血脂、尿痠、膽紅素等指標的變化情況。結果：兩組患者治療後中醫證候積分優于治療前；組間比較治療組優于對照組，具有顯著性差異（P<0.05）；兩組患者治療後心絞痛療效優于治療前；組間比較治療組優于對照組，具有顯著性差異（P<0.05）；兩組治療後心電圖較治療前均有所改變，組間比較無顯著性差異（P>0.05）；兩組患者治療後血糖、血脂、尿痠水平明顯降低，高密度脂蛋白膽固醇、血清膽紅素水平明顯升高，與治療前比較有顯著性差異（P<0.05）。組間比較顯示治療組優于對照組，具有顯著性差異（P<0.05）。結論：溫膽湯加味對痰濁型冠心病患者的相關危險因子（血糖、血脂、尿痠、膽紅素）有明顯改善作用。
목적：관찰온담탕가미대담탁형관심병환자적상관위험인자적작용。방법：선택동시부합관심병서의진단표준급중의담탁형진단표준적병례120례，수궤분위치료조화대조조，매조60례。량조균행서의규범치료，치료조가용온담탕가미，4주위1개료정，지속3개료정。관찰치료전후환자적혈당、혈지、뇨산、담홍소등지표적변화정황。결과：량조환자치료후중의증후적분우우치료전；조간비교치료조우우대조조，구유현저성차이（P<0.05）；량조환자치료후심교통료효우우치료전；조간비교치료조우우대조조，구유현저성차이（P<0.05）；량조치료후심전도교치료전균유소개변，조간비교무현저성차이（P>0.05）；량조환자치료후혈당、혈지、뇨산수평명현강저，고밀도지단백담고순、혈청담홍소수평명현승고，여치료전비교유현저성차이（P<0.05）。조간비교현시치료조우우대조조，구유현저성차이（P<0.05）。결론：온담탕가미대담탁형관심병환자적상관위험인자（혈당、혈지、뇨산、담홍소）유명현개선작용。
Objective: To study the effects of the Wendan decoction on the related risk factors in patients with turbid phlegm type coronary heart disease. Methods:According to western diagnostic criteria and TCM diagnostic criteria, 120 patients were randomly divided into the treatment group and the control group, 60 cases for each. Two groups were treated by the western medicine standardized treatment. The treatment group was treated with the Wendan decoction, 4 weeks as a course, for 3 courses. Before and after treatment, the changes of blood glucose, blood lipid, uric acid, bilirubin in the two groups were observed. Results:The TCM syndrome score in the two groups after treatment was better than before;the treatment group was better than that in the control group (P<0.05). Angina pectoris in the two groups after treatment was better than before. The treatment group was better. After treatment, the ECG in two groups was changed. There is no significant difference between two groups (P>0.05). After treatment, Blood glucose, blood lipid, uric acid levels in two groups was decreased significantly. High density lipoprotein cholesterol, serum bilirubin levels were increased obviously. There was significant difference compared with those before treatment (P<0.05). Comparison between two groups showed that the treatment group was better than the control group. Conclusion:The Wendan decoction on risk factors of turbid phlegm type of coronary heart disease (blood glucose, blood lipid, uric acid, bilirubin) was obviously effective.
